Recombinant DNA/microbial pathogens?

Answer this question ‘Yes’ if the proposal involves any of the terms below or involves any biohazardous and/or recombinant materials. For assistance, contact Research Laboratory & Safety Services at (520) 626-6850 or sends e-mail) or visit the Recombinant and Biohazardous Materials web page.

If the project you are proposing involves the handling or storage of Risk Group 3 biohazardous and/or recombinant materials that would require the use of a BSL-3 laboratory, please contact Research Laboratory & Safety Services at BSL-3 work must be approved in advance by the Institutional Biosafety Committee (IBC). You can access the documents needed to submit to the committee at  Institutional Biosafety Committee | UArizona Research, Innovation & Impact. Access and training for the BSL-3 spaces is a lengthy process, so reaching out to RLSS early in the process is optimal.

  • Adenovirus
  • Adenoassociated Virus
  • AAV
  • Cloning
  • Gene therapy
  • Genomic library
  • Microarray
  • Plasmid
  • Probes
  • Recombinant
  • Retrovirus
  • Restriction fragment polymorphism (RFLP)
  • Sequencing
  • Southern / Northern hybridization
  • Transformed cells
  • Vector
  • Bordetella pertussis
  • Campylobacter
  • Cell Culture
  • Coccidiodes
  • Chlamydia
  • Clostridium
  • Coxiella
  • Cryptosporidium
  • Cyclospora
  • Giardia
  • herpes
  • HIV
  • Influenza
  • Monkeypox
  • Mycobacterium
  • Yesinia pestis (plague)
  • Salmonella
  • Toxin
  • Vaccinia
  • SARS-CoV-2
  • Risk Group 2
  • Risk Group 3
  • Virus
  • Bacteria
  • Fungus
  • Parasite
  • Rickettsia

FAQ Page


Subscribe to our newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now